SARS‐CoV‐2 infects epithelial cells and destroys the pulmonary physiological barriers; this leads to imbalanced GM‐CSF regulation and thus elevated G‐CSF levels in the peripheral blood of patients with COVID‐19. Here, CSF2 is linked to COVID-19.